Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Aurolife Pharma LLC, priced at $1.6931 per EA under NDC 13107007501. Its NADAC has been published 382 times since Mar 6, 2019.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE
Butalbital, Acetaminophen and CaffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107007501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA204733On Market Since
4/26/2017
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has been published 382 times since Mar 6, 2019, and over the history we have for it it has declined 56.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6931 per EA |
|---|---|
| All-time high | $3.8847 (May 15, 2019) |
| All-time low | $1.6931 (Jun 17, 2026) |
| 52-week high | $2.3000 |
| 52-week low | $1.6931 |
| Median price | $2.8225 |
| Average price | $2.8772 |
| Largest weekly change | +37.8% (Jun 19, 2024) |
| Weeks tracked | 382 |
| Tracking since | Mar 6, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Aurolife Pharma LLC, is $1.6931 per EA (NDC 13107007501), effective Jun 24, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has declined 56.4%. It has been tracked across 382 weekly CMS publications since Mar 6, 2019.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
Since Mar 6, 2019, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $1.6931 (Jun 17, 2026) to a high of $3.8847 (May 15, 2019), with a median of $2.8225 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, is $0.1218 per EA — about 93% below BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE (NDC 13107007501) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification